Navigation Links
Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza
Date:7/27/2009

need to delay immunization once vaccine is available. However, those who missed an immunization opportunity early in the season are urged to seek immunization throughout the influenza season because immunization is beneficial in disease prevention as long as influenza is circulating in the community.

The vaccine formulation for the 2009-2010 season contains three strains of the influenza virus: the A/Brisbane/59/2007 (H1N1)-like virus; the A/Brisbane/10/2007 (H3N2)-like virus; and the B/Brisbane/60/2008-like virus. The three strains for the new influenza vaccine formulation were confirmed by the Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee in February 2009 and correspond with recommendations made by the World Health Organization (WHO) also in February. Influenza vaccine is formulated each year to match the strains predicted to circulate during the upcoming season. This formulation for the 2009-2010 influenza season introduces a new B strain. The two A strains are unchanged from the 2008-2009 season formulation.

The seasonal influenza vaccine does not incorporate the A/California/7/2009(H1N1) virus strain of the novel A(H1N1) influenza and is not expected to offer protection against this new type of influenza. Sanofi Pasteur is working with the WHO and the CDC on the development of a separate vaccine for the novel A(H1N1) influenza, commonly referred to as the new "swine" influenza.

Influenza Vaccine Recommendations

Approximately 260 million people, or four out of five residents of the U.S. are recommended to receive the influenza vaccine annually. The CDC recommends an( )annual influenza immunization for all children 6 months through 18 years of age; adults over 50 years of age; pregnant women; anyone with chronic health conditions, such as asthma, chronic obstructive pulmonary disease (COPD), heart disease, and diabetes; as wel
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
2. Sanofi Pasteur Receives Order from U.S. Government to Produce New Influenza A(H1N1) Vaccine
3. U.S. FDA Licenses Sanofi Pasteurs New Influenza Vaccine Manufacturing Facility
4. Sanofi-aventis Announces Good First-quarter 2009 Performance
5. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
6. Sanofi-aventis Affirms Its Commitment to Partnering with Local Communities to Improve Hispanic and African American Health
7. Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
8. Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
9. Sanofi-aventis Partners with the Hispanic Community in Miami to Increase Health Awareness, Access to Resources and Help Improve Patient Care
10. Sanofi-aventis Partners with the Hispanic Community in San Antonio to Increase Health Awareness, Access to Resources and Help Improve Patient Care
11. Sanofi-aventis Delivers 2008 Results Above Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... The holidays can be anything but joyous for people ... candles and other allergy triggers. "The dust from ... packed away in dank basements or dusty attics is ... Rachna Shah, an affiliate faculty member at Loyola University ... release. Shah, who is also an allergist at ...
(Date:12/20/2014)... 20, 2014 The Doctor’s Office Urgent Care ... better part of a decade. They’ve treated over 40,000 ... faster healthcare alternative to the Paramus area. ... new additions to their staff of top-notch board certified physicians: ... MD. These new doctors will work tirelessly to ...
(Date:12/20/2014)... New York (PRWEB) December 20, 2014 ... continue to move forward in U.S. courts, Bernstein ... study which suggests that children treated with the ... hormone linked to breast development and lactation. The ... at 34 children and adolescents who began treatment ...
(Date:12/20/2014)... 20, 2014 The aftermath of the November ... stir, not only in Hollywood, but worldwide. As ... the ripples of that attack are starting a finger-pointing game ... risk. But they are not the only ones affected, ... in for some embarrassing times ahead, agents and lawyers could ...
(Date:12/20/2014)... 2014 Developers of FCPX ... new plugin for Final Cut Pro X entitled TranSlice ... 5 allows users to create hand drawn text animations ... Austin, CEO of Pixel Film Studios. “TranSlice Volume 5 ... maintaining an easy to use interface.” , TranSlice Volume ...
Breaking Medicine News(10 mins):Health News:Holiday Trimmings Can Trigger Allergies 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... for the marathon continues to improve for both men and ... now about as fast as the record pace for the ... are running more than four times farther at speeds of ... this be? Are humans simply built better or is there ...
... AMERIGROUP Foundation, the,philanthropic arm of AMERIGROUP Corporation, honored ... at a ceremony today at,the University of Maryland ... Vince Ancona presented a,contribution in the amount of ... Breathmobile is a custom-built pediatric asthma and,allergy clinic ...
... HealthSouth,Corporation (NYSE: HLS ) has finalized, ... previously announced purchase of The Rehabilitation,Hospital of ... in,Vineland, NJ, from The Mediplex/Cumberland Rehabilitation Limited,Partnership., ... under the outstanding,leadership of Dr. Francis Bonner, ...
... and often fatal, researchers say, , , THURSDAY, July 31 (HealthDay ... dissection could lead to a rapid diagnostic test for this ... is a tear in the lining of the aorta, the ... of the body. About 2,000 people a year in North ...
... may make women more susceptible to contracting HIV, the virus ... School of Public Health researchers have found. , An analysis ... women from around the world, showed that women with bacterial ... of reproductive age were more likely than others to ...
... Late summer and early fall,are prime seasons for ... Nile Virus and EEE by health departments and ... list of 2008 cases,reported in your area:, http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount08_detailed.htm ... action and help your family and pets by,installing ...
Cached Medicine News:Health News:Story ideas for health reporters covering the summer Olympic Games 2Health News:Story ideas for health reporters covering the summer Olympic Games 3Health News:Story ideas for health reporters covering the summer Olympic Games 4Health News:Story ideas for health reporters covering the summer Olympic Games 5Health News:Story ideas for health reporters covering the summer Olympic Games 6Health News:The AMERIGROUP Foundation Honors the University of Maryland Hospital for Children's Breathmobile 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 3Health News:Gene Test Could Catch Deadly Heart Problem 2Health News:Gene Test Could Catch Deadly Heart Problem 3Health News:UNC study: Common vaginal infection may increase risk of HIV infection 2Health News:Season for West Nile Virus/EEE Reportings Begin; Mosquito Vacuum Helps Reduce Backyard Mosquito Population 2
(Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
(Date:12/19/2014)... separating membrane market has witnessed robust development with ... albeit as a later starter. In 2012, the size of ... RMB12 billion, with the proportion worldwide soaring to 16.3%. It ... market will continue its growth rate by around 20% in ... jump to roughly RMB25 billion. An integrated membrane ...
(Date:12/17/2014)... December 17, 2014 Los beneficios ... un alto nivel de gasto en investigación y desarrollo ... (finalizado el 30 de septiembre de 2014) ZEISS aumentó ... millones de euros (año anterior: 4.190 millones de euros) ... Las ganancias (EBIT) crecieron un 14 por ciento, a ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS confirma su posición en un entorno difícil 2
... ALTO, Calif., Oct. 1 Telik, Inc. (Nasdaq: TELK ... a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination ... nonsmall cell lung cancer (NSCLC) in a leading peer reviewed ... Vol. 4, No. 10. Data on this study were ...
... , MOUNTAIN VIEW, Calif., Oct. 1 IRIDEX Corporation ... FlexFiber(TM) a laser fiber probe intended for effective delivery ... procedures. Introduced at the 2009 American Academy of ... , this consumable product represents an increase in IRIDEX, ...
Cached Medicine Technology:Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer 2IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting 2
Reusable, stainless steel trephine with handle....
Reusable, stainless steel trephine with handle....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: